Adaptive Biotechnologies Corporation Analysis
| Analyst Ratings |
|
Average Target Price
|
13.00
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
4
|
|
# Buys
|
3
|
|
# Holds
|
2
|
|
# Sells
|
1
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.38
|
-0.32
|
0.06
|
15.79%
|
|
2022-06-30
|
-0.43
|
-0.37
|
0.06
|
13.95%
|
|
2022-03-31
|
-0.46
|
-0.44
|
0.02
|
4.35%
|
|
2021-12-31
|
-0.45
|
-0.43
|
0.02
|
4.44%
|
|
2021-09-30
|
-0.42
|
-0.40
|
0.02
|
4.76%
|
|
2021-06-30
|
-0.43
|
-0.35
|
0.08
|
18.60%
|
|
2021-03-31
|
-0.41
|
-0.29
|
0.12
|
29.27%
|
|
2020-12-31
|
-0.29
|
-0.33
|
-0.04
|
-13.79%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.13
|
|
2021-12-31
|
-1.47
|
|
2020-12-31
|
-1.11
|
|
2019-12-31
|
-1.69
|